Value in Health

SA50 Comparative Efficacy of Bimekizumab in Biologic/Targeted Synthetic DMARD-Naïve Patients with Axial Spondyloarthritis: Results from a Systematic Literature Review and Network Meta-Analysis.

Value in Health

A. Deodhar, P.M Machado, M. Mørup, V. Taieb, D. Willems, M.E Orme, D. Stewart, L.S Gensler

RWD136 Real-World Use of Biologic Disease-Modifying Anti-Rheumatic Drugs in US Patients with Ankylosing Spondylitis: Persistence, Factors Associated with Discontinuation, and Dosing Patterns.

Value in Health

M. Dubreuil, J.A Walsh, A. Deodhar, L.S Gensler, J.R Curtis, S. Anjohrin, O. Pilipczuk, M. Feudjo Tepie, S. Beaty, M. Mørup, V. Taieb, S. Welby

CO32 Heterotopic Ossification in Palovarotene-Treated and Untreated Individuals with Fibrodysplasia Ossificans Progressiva: Matched and Weighted Analyses.

Value in Health

M. Al Mukaddam, G. Baujat, A.M. Cheung, C. De Cunto, E.C. Hsiao, R. Keen, J. Marden, J. Signorovitch, E. Boing, R. Marino, A. Strahs, R.J. Pignolo

POSC373 Use of Aids, Assistive Devices and Adaptations by Individuals with Fibrodysplasia Ossificans Progressiva (FOP): 36-Month Results from a Global Natural History Study.

Value in Health

M Al Mukaddam, G Baujat, A Houchard, EC Hsiao, R Keen, R Marino, RJ Pignolo, FS Kaplan

PMD81 - COST EFFECTIVENESS ANALYSIS OF MAGNETIC RESONANCE-GUIDED FOCUSED ULTRASOUND FOR REFRACTORY PAINFUL BONE METASTASES.

Value in Health

M. Bucknor, J. Matuoka, F. Chan, S.R. Secoli, J. Kahn